Eris Lifesciences' board greenlit Sujesh Vasudevan's re-appointment as Independent Director for 5 years starting July 2027. The company also announced its 20th Annual General Meeting will be held on September 25, 2026.
Eris Lifesciences management will meet HBM Partners AG in a 1x1 institutional investor meeting on Thursday, August 27, 2026. Discussions will be based on publicly available documents, with no undisclosed price sensitive information shared.
